
CDXS vs GEVO
$CDXS vs $GEVO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
CDXS vs GEVO: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+5.7%). Split-adjusted daily closes.
- ·CDXS is the weaker of the two on trend, below both its 50- and 200-day averages, while GEVO has held above one of them.
- ·Neither kept up with the market over the past year: CDXS -35.7% and GEVO -13.9%, against the S&P 500 at +5.7%.
- ·GEVO has support 7.4% below at $1.49; CDXS has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
CDXS vs GEVO: the quick read
- ·GEVO is the larger company by market cap ($413M vs $115M).
- ·GEVO has been more active on our scanner (225 vs 84 alerts in 30 days).
- ·CDXS has the smaller float (106.4M vs 230.2M), which tends to mean sharper, more volatile moves.
- ·Both are industrial organic chemicals names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 225 and 84 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·CDXS is the one in play today, trading about 2.2x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Watching CDXS or GEVO? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing CDXS and GEVO on TheDesperateTrader.
- Is CDXS or GEVO the better stock?
- "Better" depends on your goal, and these two are not alike. GEVO is the larger company by market cap ($413M vs $115M). GEVO has been more active on our scanner (225 vs 84 alerts in 30 days). CDXS has the smaller float (106.4M vs 230.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between CDXS and GEVO?
- The differences that matter: GEVO is roughly 4x the size of the other by market cap ($115M vs $413M); they trade at very different share prices ($0.91 vs $1.61); CDXS sits at 0% of its 52-week range against 28% for GEVO; our scanner flagged CDXS 84 times in the last 30 days against 225 for GEVO. Everything above is measured from the latest completed session and SEC filings.
- Which of CDXS and GEVO is more active right now?
- Right now CDXS is at about 2.2x its normal volume and GEVO is at about 1.0x, so CDXS is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is CDXS or GEVO in the stronger trend?
- CDXS is below its 50-day average of $1.25 and below its 200-day average of $1.78; GEVO is above its 50-day average of $1.38 and below its 200-day average of $1.68. GEVO leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading CDXS or GEVO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore CDXS and GEVO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.